Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Frontiers in Chemistry|September 26, 2019
Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell LinesMatic Pavlin, Luca Gelsomino, Ines Barone, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 24, 2021
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectivesInes Barone, Amanda Caruso, Luca Gelsomino, et al.
Nutrients|October 17, 2019
Endemic Goiter and Iodine Prophylaxis in Calabria, a Region of Southern Italy: Past and PresentCinzia Giordano, Ines Barone, Stefania Marsico, et al.
Cancers|January 13, 2019
Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed MechanismsSebastiano Andò, Luca Gelsomino, Salvatore Panza, et al.
Cancers|August 9, 2020
The Biology of Exosomes in Breast Cancer Progression: Dissemination, Immune Evasion and Metastatic ColonizationCinzia Giordano, Giusi La Camera, Luca Gelsomino, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 6, 2016
Impact of R264C and R264H polymorphisms in human aromatase functionRoberta Baravalle, Giovanna Di Nardo, Andrea Bandino, et al.
Infectious Agents and Cancer|October 13, 2017
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressivenessFrancesca Caccuri, Francesca Giordano, Ines Barone, et al.
Cancers|September 17, 2020
The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical StudiesGiuseppina Augimeri, Cinzia Giordano, Luca Gelsomino, et al.
International Journal of Molecular Sciences|December 23, 2020
Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast CancerGiuseppina Augimeri, Luca Gelsomino, Pierluigi Plastina, et al.
Breast Cancer Research and Treatment|February 12, 2009
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305Cinzia Giordano, Yukun Cui, Ines Barone, et al.
Pageof 10